Parallax Volatility Advisers
GEN

Parallax Volatility Advisers’s Genesis Healthcare, Inc. GEN Stock Holding History

Parallax Volatility Advisers’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,544
Closed -$4K – 4879
2017
Q4 		$4K Buy
+5,544
New +$4.96K ﹤0.01% 3846

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Parallax Volatility Advisers's GEN Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Genesis Healthcare, Inc. (GEN) in Q1 2018, closing a stake of 5,544 shares — an estimated $4K sold.

Parallax Volatility Advisers first reported a position in GEN in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 67 funds tracked by Wall St. Rank hold GEN as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Genesis Healthcare, Inc. position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 5,544 Genesis Healthcare, Inc. shares in Q1 2018, an estimated $4K.
  • Parallax Volatility Advisers first reported a position in Genesis Healthcare, Inc. in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Genesis Healthcare, Inc. position peaked at $4K in Q4 2017.
  • 67 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.